Erratum to modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma
Erratum

Erratum to modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma

Editorial Office

Annals of Translational Medicine

Correspondence to: Editorial Office. Annals of Translational Medicine. Email: editor@atmjournal.org.

Submitted Jun 05, 2022. Accepted for publication Jun 15, 2022.

doi: 10.21037/atm-2022-18


Erratum to: Ann Transl Med xxxx;10:40

In the article (1) entitled “Modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma”, two errors were found in figures and author information.

Firstly, the authors accidentally used the incorrect version of the Figure 2G. The corrected Figure 2G can be found below.

Finally, there are some mistakes in the authors’ information.

The order of the 2th author Hao Zheng should be moved to be the 5th author and the superscript “#” of Hao Zheng should be removed. The correct authors’ information and contributions are as follows:

Feng-Qiu Chen1#, Ting Gu2#, Yu-Hua Hu2#, Le Yang3, Hao Zheng4, Zhi-Ping Huang5, Guang-Lei Qiao6, Hong-Jie Li7

1The Department of Biobank, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2Department of Oral Pathology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3National Liver Tissue Bank, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; 4The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; 5Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, Guangzhou, China; 6Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7Department of General Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Contributions: (I) Conception and design: ZP Huang, GL Qiao, HJ Li; (II) Administrative support: FQ Chen; (III) Provision of study materials or patients: L Yang; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

#These authors contributed equally to this work.

Correspondence to: Hong-Jie Li. Department of General Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Zhizaoju Rd. 639, Shanghai 200023, China. Email: shanghaileester@gmail.com; Zhi-Ping Huang. Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, 111 Liuhua Road, Guangzhou 510010, China. Email: surg411@163.com; Guang-Lei Qiao. Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai 200336, China. Email: qiaoguanglei26@126.com.

The authors apologize for these errors and state that these errors do not change the scientific conclusions of the article in any way.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Chen FQ, Zheng H, Gu T, et al. Modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma. Ann Transl Med 2022;10:40. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum to modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma. Ann Transl Med 2022;10(16):917. doi: 10.21037/atm-2022-18

Download Citation